<DOC>
	<DOC>NCT01825447</DOC>
	<brief_summary>The main purpose of this study is to simulate if oxycodone and naltrexone combination capsules (ALO-02) were to be tampered with by dissolving and then injecting intravenously for the purpose of getting high.</brief_summary>
	<brief_title>A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users</brief_title>
	<detailed_description />
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Healthy subjects Nondependent, recreational opioid users Must include at least one of these routes of administration: intranasal use on at least 3 occassions in the past year or intravenous use on at least 1 occasion in the past year before Screening (Visit 1). Diagnosis of substance and/or alcohol dependence Subject has participated in, is currently participating in, or seeking treatment for substance and/or alcohol related disorder History of sleep apnea.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>abuse potential</keyword>
	<keyword>abuse liability</keyword>
	<keyword>drug liking</keyword>
	<keyword>oxycodone</keyword>
	<keyword>naltrexone</keyword>
	<keyword>intravenous</keyword>
	<keyword>pharmacodynamic</keyword>
</DOC>